Scientists wipe out deadly brain tumors in every mouse tested with new cancer therapy
Reported byScienceDaily (UCSF) ↗·Sourced by Goodlede
UC San Francisco researchers engineered immune cells called B-SYNC CAR-T that switch on only inside the brain. In two mouse models they eliminated diffuse midline glioma (DMG), an aggressive childhood brain cancer that is almost always fatal within a year, and kept new tumors from forming when cancer cells were reintroduced weeks later. The study was published October 28 in Science Translational Medicine; clinical trials at UCSF Health could begin as early as April 2027.
Tested in mice only. More research is needed before the findings can be translated into human treatments.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at ScienceDaily (UCSF)
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Kindness
Chihuahua found after crossing I-10, reunited with owner thanks to Valley neighbors
KNXV ABC15 Phoenix Good News · Verified
Health
CMS Approves Traditional Healing Waivers in Utah and Maine, Inclusion of Utah Urban Indian Organizations
National Council of Urban Indian Health · Verified
Animals
As Antarctic blue whales advance along the road to recovery, continued oversight is key
University of Washington · Verified